Unknown

Dataset Information

Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice.


ABSTRACT:

Aims/hypothesis

Obesity is strongly associated with the development of non-alcoholic fatty liver disease (NAFLD). The cytokine osteopontin (OPN) was recently shown to be involved in obesity-induced adipose tissue inflammation and reduced insulin response. Accumulating evidence links OPN to the pathogenesis of NAFLD. Here we aimed to identify the role of OPN in obesity-associated hepatic steatosis and impaired hepatic glucose metabolism.

Methods

Wild-type (WT) and Opn (also known as Spp1) knockout (Opn (-/-)) mice were fed a high-fat or low-fat diet to study OPN effects in obesity-driven hepatic alterations.

Results

We show that genetic OPN deficiency protected from obesity-induced hepatic steatosis, at least in part, by downregulating hepatic triacylglycerol synthesis

SUBMITTER: Kiefer FW 

PROVIDER: S-EPMC3131508 | biostudies-literature | 2011 Aug

REPOSITORIES: biostudies-literature